If you develop facial swelling, lip swelling, or difficulty breathing, seek urgent help and do not take further doses
You are a strict vegan or vegetarian and need to replenish depleted stores quickly
Tirzepatide is the first GLP-1/GIP receptor co-agonist approved for the treatment of type 2 diabetes and obesity
During shortages of Wegovy, Ozempic, Mounjaro, and Zepbound, the FDA exercised temporary enforcement discretion , allowing compounding pharmacies to help meet patient demand. Once manufacturing stabilized: Semaglutide injection products were removed from the FDA Drug Shortage List Tirzepatide injection products were formally declared resolved Compounding reverted to pre-shortage federal and state limits Broad, shortage-based compounding is no longer allowed in 2026
Benefits of Semaglutide and Tirzepatide Appetite Suppression: Helps reduce hunger and cravings
Retatrutide is more powerful than Ozempic but that doesn't mean it's the right drug for you